Form 4: ProAssurance Corp Merger Completes, Director Stock Vested
Merger Completion Filing
ProAssurance Corporation's merger with The Doctors Company subsidiary has been finalized, resulting in the conversion of director deferred stock into cash payments.
Summary
- ProAssurance Corporation (PRA) has completed its merger with The Doctors Company, effective June 26, 2026.
- Scott C. Syphax, a Director, reported transactions related to this merger.
- Deferred shares held by Mr. Syphax under the ProAssurance Corporation Director Deferred Stock Compensation Plan were converted into the right to receive cash.
- Each share of ProAssurance Corporation's common stock outstanding at the effective time of the merger was converted into $25.00 in cash, without interest.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on the completion of a merger and the conversion of executive compensation awards, rather than new operational or financial performance.
Positives
- The merger has been successfully completed, providing a clear outcome for shareholders and stakeholders.
- Director Syphax's deferred stock awards were converted into a cash payout, realizing value from his holdings.
Negatives
- The company's common stock will cease to be publicly traded as it becomes a wholly owned subsidiary of The Doctors Company.
Future Outlook
The filing indicates the completion of a merger, which signifies a change in the corporate structure rather than providing forward-looking financial guidance for ProAssurance Corporation as an independent entity.
Industry Context
StockSavvy.ai notes that this Form 4 filing details the completion of a significant M&A event in the insurance sector, specifically within the healthcare liability insurance space, where consolidation is a recurring theme.
Stakeholder Impact
- Shareholders: Will receive $25.00 in cash per share, realizing their investment in ProAssurance Corporation.
- Employees: Their employment status and terms may be subject to integration plans between ProAssurance Corporation and The Doctors Company.
- Management: Will transition to roles within the new corporate structure, potentially with changes in reporting lines and responsibilities.
Next Steps
- ProAssurance Corporation will operate as a wholly owned subsidiary of The Doctors Company.
- Shareholders will receive $25.00 in cash per share.
Key Dates
| Date | Description |
|---|---|
| 03/19/2025 | Date of the Agreement and Plan of Merger (the "Merger Agreement") |
| 06/26/2026 | Effective Date of the Merger and Transaction Date for Director Syphax's stock conversion. |
Keywords
ProAssurance Corporation, The Doctors Company, Merger, SEC Form 4, Director Stock, Deferred Stock, Cash Payout, PRA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.